DesignMedix Receives $525,000 Series B Financing

  • Feed Type
  • Date
    7/16/2013
  • Company Name
    DesignMedix
  • Mailing Address
    2828 SW Corbett Ave Portland, OR 97201
  • Company Description
    DesignMedix is developing drugs to address the large medical need and markets associated with the rise in drug resistance in multiple diseases. Drug resistance is a huge global and national problem and additional drugs are needed to provide therapeutic options for infectious diseases.
  • Website
    http://www.designmedix.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $525,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.